VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 117 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $545,616 | -32.2% | 126,300 | +3.4% | 0.00% | -100.0% |
Q2 2023 | $805,298 | -2.9% | 122,200 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $829,738 | -17.8% | 122,200 | -10.5% | 0.00% | 0.0% |
Q4 2022 | $1,009,474 | -23.8% | 136,600 | +1.9% | 0.00% | 0.0% |
Q3 2022 | $1,324,000 | -7.8% | 134,000 | +1.7% | 0.00% | 0.0% |
Q2 2022 | $1,436,000 | -3.6% | 131,700 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $1,490,000 | -22.7% | 131,700 | +7.2% | 0.00% | 0.0% |
Q4 2021 | $1,927,000 | -8.5% | 122,800 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $2,105,000 | -19.1% | 122,800 | +1.5% | 0.00% | -50.0% |
Q2 2021 | $2,603,000 | +38.6% | 121,000 | -3.2% | 0.00% | +100.0% |
Q1 2021 | $1,878,000 | +15.6% | 125,000 | +1.1% | 0.00% | 0.0% |
Q4 2020 | $1,624,000 | +36.0% | 123,600 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,194,000 | -12.9% | 123,600 | +3.2% | 0.00% | 0.0% |
Q2 2020 | $1,371,000 | +42.1% | 119,800 | +28.7% | 0.00% | 0.0% |
Q1 2020 | $965,000 | -35.9% | 93,100 | +1.4% | 0.00% | -50.0% |
Q4 2019 | $1,506,000 | +26.7% | 91,800 | +2.6% | 0.00% | +100.0% |
Q3 2019 | $1,189,000 | -4.2% | 89,500 | +1.6% | 0.00% | 0.0% |
Q2 2019 | $1,241,000 | -29.4% | 88,100 | -7.7% | 0.00% | -50.0% |
Q1 2019 | $1,757,000 | -27.4% | 95,500 | +3.1% | 0.00% | -33.3% |
Q4 2018 | $2,420,000 | +18.5% | 92,600 | +4.0% | 0.00% | +50.0% |
Q3 2018 | $2,043,000 | +20.5% | 89,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,695,000 | +13.0% | 89,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $1,500,000 | +42.0% | 89,000 | +28.1% | 0.00% | +100.0% |
Q4 2017 | $1,056,000 | -15.1% | 69,500 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $1,244,000 | +9.8% | 69,500 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $1,133,000 | +27.6% | 69,500 | +9.6% | 0.00% | 0.0% |
Q1 2017 | $888,000 | -12.2% | 63,400 | 0.0% | 0.00% | -50.0% |
Q4 2016 | $1,011,000 | -4.2% | 63,400 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $1,055,000 | +48.8% | 63,400 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $709,000 | +31.8% | 63,400 | -4.9% | 0.00% | 0.0% |
Q1 2016 | $538,000 | +7.8% | 66,700 | +24.4% | 0.00% | 0.0% |
Q4 2015 | $499,000 | -17.5% | 53,600 | 0.0% | 0.00% | -50.0% |
Q3 2015 | $605,000 | +7.8% | 53,600 | +21.3% | 0.00% | +100.0% |
Q2 2015 | $561,000 | +43.1% | 44,200 | +4.7% | 0.00% | 0.0% |
Q1 2015 | $392,000 | -35.1% | 42,200 | 0.0% | 0.00% | -50.0% |
Q4 2014 | $604,000 | +53.3% | 42,200 | +11.1% | 0.00% | 0.0% |
Q3 2014 | $394,000 | -35.9% | 38,000 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $615,000 | – | 38,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |